Target Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford, OX3 7FZ, UK.
Chinese Academy for Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford, OX3 7FZ, UK.
Nat Commun. 2023 Nov 24;14(1):7710. doi: 10.1038/s41467-023-43520-8.
The spatial organisation of cellular protein expression profiles within tissue determines cellular function and is key to understanding disease pathology. To define molecular phenotypes in the spatial context of tissue, there is a need for unbiased, quantitative technology capable of mapping proteomes within tissue structures. Here, we present a workflow for spatially-resolved, quantitative proteomics of tissue that generates maps of protein abundance across tissue slices derived from a human atypical teratoid-rhabdoid tumour at three spatial resolutions, the highest being 40 µm, to reveal distinct abundance patterns of thousands of proteins. We employ spatially-aware algorithms that do not require prior knowledge of the fine tissue structure to detect proteins and pathways with spatial abundance patterns and correlate proteins in the context of tissue heterogeneity and cellular features such as extracellular matrix or proximity to blood vessels. We identify PYGL, ASPH and CD45 as spatial markers for tumour boundary and reveal immune response-driven, spatially-organised protein networks of the extracellular tumour matrix. Overall, we demonstrate spatially-aware deep proteo-phenotyping of tissue heterogeneity, to re-define understanding tissue biology and pathology at the molecular level.
细胞蛋白质表达谱在组织内的空间组织决定了细胞功能,是理解疾病病理的关键。为了在组织的空间背景下定义分子表型,需要有一种能够在组织结构内绘制蛋白质组图谱的无偏、定量技术。在这里,我们提出了一种用于组织的空间分辨、定量蛋白质组学的工作流程,该流程生成了源自人类非典型畸胎样/横纹肌样肿瘤的组织切片的蛋白质丰度图谱,具有三个空间分辨率,最高分辨率为 40μm,以揭示数千种蛋白质的独特丰度模式。我们采用了不需要先验知识的空间感知算法来检测具有空间丰度模式的蛋白质和途径,并在组织异质性和细胞特征(如细胞外基质或接近血管)的背景下对蛋白质进行相关性分析。我们确定了 PYGL、ASPH 和 CD45 作为肿瘤边界的空间标记物,并揭示了细胞外肿瘤基质中免疫反应驱动的、空间组织的蛋白质网络。总的来说,我们展示了组织异质性的空间感知深度蛋白质表型,以重新定义分子水平上的组织生物学和病理学理解。